###begin article-title 0
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
###end article-title 0
###begin p 1
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 616 622 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 701 704 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 757 762 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1026 1027 1026 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1050 1051 1050 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1322 1328 1322 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 1465 1470 1461 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1516 1519 1512 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1588 1594 1584 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 1721 1725 1717 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
Frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) is caused by mutations in the MAPT gene, encoding the tau protein that accumulates in intraneuronal lesions in a number of neurodegenerative diseases. Several FTDP-17 mutations affect alternative splicing and result in excess exon 10 (E10) inclusion in tau mRNA. RNA reprogramming using spliceosome-mediated RNA trans-splicing (SMaRT) could be a method of choice to correct aberrant E10 splicing resulting from FTDP-17 mutations. SMaRT creates a hybrid mRNA through a trans-splicing reaction between an endogenous target pre-mRNA and a pre-trans-splicing RNA molecule (PTM). However, FTDP-17 mutations affect the strength of cis-splicing elements and could favor cis-splicing over trans-splicing. Excess E10 inclusion in FTDP-17 can be caused by intronic mutations destabilizing a stem-loop protecting the 5' splice site at the E10/intron 10 junction. COS cells transfected with a minigene containing the intronic +14 mutation produce exclusively E10+ RNA. Generation of E10- RNA was restored after co-transfection with a PTM designed to exclude E10. Similar results were obtained with a target containing the exonic N279K mutation which strengthens a splicing enhancer within E10. Conversely, increase or decrease in E10 content was achieved by trans-splicing from a target carrying the Delta280K mutation, which weakens the same splicing enhancer. Thus E10 inclusion can be modulated by trans-splicing irrespective of the strength of the cis-splicing elements affected by FTDP-17 mutations. In conclusion, RNA trans-splicing could provide the basis of therapeutic strategies for impaired alternative splicing caused by pathogenic mutations in cis-acting splicing elements.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C1">1</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C2">2</xref>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C3">3</xref>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C4">4</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C6">6</xref>
Tauopathies are major diseases of the central nervous system characterized neuropathologically by intracellular filamentous inclusions formed by the microtubule-associated protein tau in affected neurons (1,2). Tauopathies include dementias such as Alzheimer's disease and some forms of frontotemporal dementia (3). Definitive evidence for the pathogenic importance of tau was provided by the discovery of dominant mutations in the MAPT gene, the gene encoding tau, in the rare dementia, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) (4-6).
###end p 3
###begin p 4
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 478 479 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 552 557 <span type="species:ncbi:9606">human</span>
The MAPT gene comprises 16 exons and alternative splicing of exons 2, 3 and 10 generates six isoforms in the brain. Exon 10 (E10) encodes the second of four imperfect 31-32 amino-acid microtubule-binding repeats in the C-terminal half of the protein. Exclusion or inclusion of E10 generate tau isoforms with three (3R tau, E10-) or four (4R tau, E10+) microtubule-binding repeats, the latter having an increased affinity for microtubules. E10 is expressed only in adults and E10+ and E10- isoforms are expressed in approximately equal amounts in adult human brain.
###end p 4
###begin p 5
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C7">7</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C4">4</xref>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C6">6</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C8">8</xref>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C9">9</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C10">10</xref>
To date, more than thirty-five MAPT mutations have been associated with FTDP-17. Most missense mutations reduce the affinity of tau for microtubules (7), whereas silent or intronic mutations affect E10 splicing and can result in an up to 6-fold excess of tau mRNA containing E10 and in an elevated 4R/3R ratio (4,6,8,9). Elevated 4R/3R ratio is likely to have functional consequences, for example in the regulation of axonal transport (10).
###end p 5
###begin p 6
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 211 214 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 217 219 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C11">11</xref>
###xml 260 266 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 427 433 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 528 534 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 585 587 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C12">12</xref>
###xml 703 704 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 711 712 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 763 765 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C13">13</xref>
###xml 925 928 923 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 963 966 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 981 986 979 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1148 1150 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C14">14</xref>
###xml 1151 1153 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C15">15</xref>
###xml 1250 1254 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 1317 1319 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C16">16</xref>
###xml 1320 1322 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C17">17</xref>
###xml 1581 1586 1579 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1608 1614 1606 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
From a therapeutic perspective, correcting defective alternative splicing is best achieved by direct intervention at the RNA level. RNA can be reprogrammed by using spliceosome-mediated RNA trans-splicing (SMaRT(R)) (11). SMaRT creates a hybrid mRNA through a trans-splicing reaction mediated by the spliceosome between the 5' splice site of an endogenous target pre-mRNA and the 3' splice site of an exogenously delivered pre-trans-splicing RNA molecule (PTM). Conversely, a PTM can be designed to carry the 5' splice site and trans-splice to the 3' splice site of a specific target (12). A typical application of SMaRT is the correction of loss-of-function mutations. We have shown previously that E10- to E10+ tau RNA conversion could be achieved using SMaRT (13). Thus, SMaRT could be a method of choice to correct aberrant E10 splicing resulting from FTDP-17 mutations. However, FTDP-17 mutations affect the strength of cis-splicing elements and could favor cis-splicing over trans-splicing. For instance, most intronic mutations are clustered at the exon 10-intron 10 junction and disrupt a stem-loop structure protecting the 5' splice site (14,15). Furthermore, with the exception of the P301L/S mutations, mutations within E10 are located in cis-acting splicing regulatory elements and promote E10 retention (16,17). We therefore addressed the question of the potential effectiveness of SMaRT to correct aberrant E10 splicing caused by FTDP-17 mutations. Here we show that elevated or reduced E10 inclusion caused by intronic or exonic FTDP-17 mutations can be reversed by trans-splicing. Hence, RNA trans-splicing could provide the basis for the development of promising therapeutic strategies for impaired alternative splicing, especially in the context of neurological diseases.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
Tau PTM constructs
###end title 8
###begin p 9
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F1">1</xref>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C18">18</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C13">13</xref>
###xml 647 653 647 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 980 981 980 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F2">2</xref>
###xml 985 990 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1238 1239 1238 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F2">2</xref>
###xml 1424 1430 1424 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 212 217 <span type="species:ncbi:9606">human</span>
We have shown previously that E10 could be introduced in tau RNA by SMaRT (13). We have now designed a PTM, TauPTM9, to exclude E10. TauPTM9 comprises a binding domain hybridizing with the 3' end of intron 9 and human tau exons 11-13 followed by a FLAG epitope sequence in the coding sequence (Fig. 1). COS cells were co-transfected with TauPTM9 and the LI9/LI10 tau minigene consisting of the full genomic MAPT sequence from exon 9 to exon 11, including exons 9, 10, 11 and the entire introns 9 and 10 (18). As a positive control, cells were also co-transfected with the minigene and TauPTM6, designed to introduce E10 in tau RNA (13). To detect trans-spliced products, RNA was analyzed by RT-PCR with a minigene-specific forward primer, VctF, corresponding to a pCIneo vector sequence, and the PTM-specific reverse primer, FLAGR, complementary to the FLAG epitope sequence. Using this primer combination, a product of 773 bp was detected in cells transfected with TauPTM9 (Fig. 2A). Trans-splicing was also detected in cells transfected with the minigene and TauPTM6, that has the same binding and trans-splicing domains as TauPTM9. The 93 bp difference in size between the TauPTM6 (866 bp) and TauPTM9 products correspond to E10 (Fig. 2A). Sequencing of VctF-FLAGR products confirmed that exact exon 9-exon 10 and exon 9-exon 11 junctions had been generated using TauPTM6 and TauPTM9, respectively, and demonstrates that trans-splicing has occurred between minigene transcripts and either PTM.
###end p 9
###begin p 10
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 362 367 <span type="species:ncbi:4932">yeast</span>
Structure of TauPTM6 and TauPTM9 and resulting trans-spliced products. The coding sequence of TauPTM6 and TauPTM9 consists of exons 10-13 or exons 11-13, respectively, followed by a 24 nt FLAG epitope sequence. The trans-splicing domain of the PTMs comprises a 125 nt binding domain (BD) complementary to the 3' end of tau intron 9 as well as a strong conserved yeast branch point sequence (BP), a 26 nt polypyrimidine tract (PPT), an AG acceptor site and a spacer sequence separating the binding domain and the branch point. Arrows indicate the locations of the PCR primers used to detect cis- and trans-splicing events.
###end p 10
###begin p 11
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 141 142 141 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 479 480 479 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 571 575 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 580 586 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Trans-splicing modulation of E10 usage in tau transcripts. COS cells were co-transfected with the LI9/LI10 minigene and TauPTM6 or TauPTM9. (A) RT-PCR analysis with the forward primer VctF, specific for the target minigene and the PTM-specific reverse primer FLAGR, complementary to the FLAG epitope sequence, demonstrates trans-splicing between minigene transcripts and PTMs. The difference in size between the products generated using Tau PTM6 and TauPTM9 corresponds to E10. (B) Change in E10 inclusion after co-transfection of LI9/LI10 with TauPTM6 and TauPTM9. Both cis- and trans-spliced products were detected by RT-PCR with the forward primer VctF and the reverse primer 11R, corresponding to an exon 11 sequence. Co-transfection with TauPTM6 or TauPTM9 resulted in an increase or decrease of E10 inclusion, respectively.
###end p 11
###begin p 12
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F2">2</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C13">13</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F2">2</xref>
###xml 676 679 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
We next analyzed whether trans-splicing with TauPTM9 was accompanied by a reduction in E10 inclusion in the total mature RNA (i.e. cis-spliced and trans-spliced) derived from LI9/LI10. Reverse transcribed RNA was amplified with the VctF primer, as above, and the reverse primer 11R complementary to an exon 11 sequence, that detects both cis- and trans-spliced products. Co-transfection of LI9/LI10 with TauPTM9 resulted in a decrease in E10 inclusion (Fig. 2B). Conversely, and as reported previously (13), co-transfection with TauPTM6 resulted in increased E10 inclusion (Fig. 2B). These results show that E10 usage can be modulated in either direction, irrespective of the cis-splicing fate on an individual targeted pre-mRNA.
###end p 12
###begin title 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
Trans-splicing reduction of E10 excess caused by intronic MAPT mutations
###end title 13
###begin p 14
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C19">19</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C14">14</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C15">15</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C19">19</xref>
###xml 773 774 773 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C4">4</xref>
###xml 946 948 946 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 965 970 965 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 1019 1021 1019 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 1042 1043 1042 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1074 1075 1074 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
###xml 1117 1122 1117 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 1156 1157 1156 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1168 1169 1168 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
FTDP-17 MAPT mutations affecting splicing are located in splicing regulatory elements and most produce excess E10 inclusion. We assessed whether the level of E10 inclusion in tau RNA could be reduced by trans-splicing in the context of FTDP-17 mutations. As mutations are within or close to E10, trans-splicing assays with mutant targets were performed using the TauEx9-11WT minigene backbone, with minimal intronic sequences flanking E10 (19) (Fig. 3A). The sequence of the exon 10/intron 10 junction predicts a stem-loop structure regulating E10 splicing by protecting the 5' splice site. FTDP-17 mutations +3 to +16 destabilize the stem loop and enhance E10 inclusion (14,15,19). Among these the +14 DDPAC mutation is one of the most potent at increasing E10 inclusion (4). To confirm that the +14 mutation resulted in E10 excess in mature tau RNA, tau splicing was compared between COS cells transfected with the wild-type minigene, TauEx9-11WT or the TauEx9-11DDPAC minigene, containing the +14 mutation. TauEx9-11WT generated mostly E10+ RNA with a small amount of E10- RNA (Fig. 3B). In contrast, the TauEx9-11DDPAC minigene produced exclusively E10+ RNA (Fig. 3B).
###end p 14
###begin p 15
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 316 317 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 412 414 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 434 435 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 478 469 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 492 497 488 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 522 523 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 546 555 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
###xml 581 582 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Splicing pattern of minigenes containing FTDP-17 mutations. (A) Structure of the MAPT minigenes incorporating the exonic N279K and Delta280K mutations or the intronic DDPAC +14 mutation. The backbone minigene, TauEx9-11, consists of tau exons 9-10-11 and 498 bp 5' and 264 bp 3' of intronic sequences flanking E10. (B) Splicing was assayed by RT-PCR using primers VctF and 11R in transfected COS cells. TauEx9-11WT produces mainly E10+ RNA; the mutants minigenes, TauEx9-11DDPAC and TauEx9-11N279K, produce exclusively E10+ RNA, whereas TauEx9-11Delta280K produces an excess of E10- RNA. Arrows indicate the locations of the PCR primers used to detect splice isoforms.
###end p 15
###begin p 16
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 164 169 164 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F4">4</xref>
###xml 484 489 484 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F4">4</xref>
###xml 650 655 650 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F4">4</xref>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 974 975 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1025 1029 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 1243 1244 1231 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F4">4</xref>
To determine whether RNA lacking E10 could be generated by trans-splicing from a target containing the +14 mutation COS cells were co-transfected with the TauEx9-11DDPAC minigene and TauPTM9 and analyzed for occurrence of trans-splicing and levels of E10 inclusion using the VctF-FLAGR or VctF-11R primer combinations. Trans-splicing was first confirmed for the wild-type minigene, TauEx9-11WT, and Tau PTM6 or TauPTM9 (Fig. 4A, B). Analysis of cells co-transfected with the TauEx9-11DDPAC minigene and TauPTM6 or TauPTM9 demonstrated trans-splicing between transcripts from the minigene and either PTM (Fig. 4C). In the absence of PTM, the TauEx9-11DDPAC minigene produced E10+ RNA only. In contrast, products lacking E10 were generated in cells co-transfected with TauPTM9 (Fig. 4D). Based on the reduction in the percentage of E10 inclusion estimated by semi-quantitative PCR, restoration of E10- RNA was achieved with a approximately11% efficiency. The generation of E10- RNA is not the consequence of a direct change in cis-splicing activity secondary to the blocking of a potential splicing enhancer in intron 9 by the binding of the PTM as such products were not observed with TauPTM6 which has the same binding domain as TauPTM9 (Fig. 4D).
###end p 16
###begin p 17
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 167 168 167 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 173 174 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 192 197 192 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 242 243 242 243 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 565 567 565 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 621 626 621 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 648 649 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 666 667 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Trans-splicing reduction of E10 inclusion in tau transcripts with the intronic +14 mutation. COS cells were co-transfected with a wild-type tau minigene, TauEx9-11WT (A and B) or the TauEx9-11DDPAC minigene containing the +14 mutation (C and D) and TauPTM6 or TauPTM9 and analyzed by RT-PCR. (A and C) PCR analysis with primers VctF and FLAGR demonstrates trans-splicing between minigene transcripts and PTMs. (B and D) E10 usage after co-transfection with the minigenes was analyzed by RT-PCR using the VctF-11R primer combination. (B) Co-transfection of TauEx9-11WT with TauPTM9 reduced E10 inclusion. (D) The TauEx9-11DDPAC minigene produces E10+ RNA only and E10- products were generated after co-transfection with TauPTM9. Co-transfection with TauPTM6 had no effect on E10 inclusion.
###end p 17
###begin p 18
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F5">5</xref>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F5">5</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F5">5</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F5">5</xref>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
To exclude the possibility that the hybrid RNA observed was the result of recombination events at the DNA level between minigene and PTM PCR analysis was conducted with or without reverse transcription and with an extension time sufficient to amplify potential recombination products. No trans-splicing (Fig. 5A) or cis- and trans-splicing (Fig. 5B) products were detected when the reverse transcription step was omitted. In addition, no large size species that would have been indicative of recombination were amplified from the traces of DNA present in the RNA preparation using the VctF-FLAGR primer combination (Fig. 5A). In contrast minigene DNA was readily detected using the VctF-11R primer combination (Fig. 5B). Therefore E10 can be skipped by trans-splicing in the presence of a constitutively available 5' splice site in the target.
###end p 18
###begin p 19
###xml 121 126 121 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 254 255 254 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 302 308 302 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Absence of recombination between minigene and PTM at the DNA level. RNA isolated from cells co-transfected with TauEx9-11DDPAC and TauPTM6 or TauPTM9 was analyzed by PCR with (+RT) or without (-RT) prior reverse transcription. No cis- or trans-splicing (A and B) products were detected without RT. (A) Trans-splicing products only are amplified using the VctF-FLAGR primer combination; no larger size species were detected with or without RT. (B) In contrast, in addition to cis- and trans-splicing products, minigene DNA was readily amplified from the traces of DNA present in the RNA preparation using the VctF-11R primer combination.
###end p 19
###begin title 20
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
Trans-splicing reduction of E10 excess caused by exonic MAPT mutations
###end title 20
###begin p 21
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C16">16</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C20">20</xref>
###xml 245 250 245 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
###xml 341 346 341 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 497 503 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 550 555 550 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F6">6</xref>
###xml 634 639 634 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 789 790 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F6">6</xref>
The N279K mutation is located within an exonic splicing enhancer (ESE) in E10, and increases E10 inclusion by facilitating the use of the 3' splice site of intron 9 (16,20). In transfected cells, a minigene carrying the N279K mutation, TauEx9-11N279K, produces exclusively E10+ RNA (Fig. 3B). COS cells were co-transfected with the TauEx9-11N279K minigene and analyzed for occurrence of trans-splicing and levels of E10 inclusion, as earlier. Analysis with the VctF and FLAGR primers demonstrated trans-splicing between transcripts from the TauEx9-11N279K minigene and both TauPTM6 and Tau PTM9 (Fig. 6A). Co-transfection of TauEx9-11N279K with TauPTM9 resulted in the appearance of E10- products with a approximately7% efficiency, whereas co-transfection with TauPTM6 had no effect (Fig. 6B).
###end p 21
###begin p 22
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 153 158 149 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 160 161 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 166 167 162 163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 185 194 181 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
###xml 196 197 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 202 203 194 195 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 326 332 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 535 540 527 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 587 588 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 677 686 669 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
###xml 713 714 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 722 723 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 756 757 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Trans-splicing modulation of E10 usage in tau transcripts with the exonic N279K and Delta280K mutations. COS cells were co-transfected with the TauEx9-11N279K (A and B) or the TauEx9-11Delta280K (C and D) tau minigenes and TauPTM6 or TauPTM9 and analyzed by RT-PCR. (A and C) PCR analysis with primers VctF-FLAGR demonstrates trans-splicing between minigene transcripts and PTMs. (B and D) E10 usage after co-transfection with the minigenes was analyzed by RT-PCR using the VctF-11R primer combination. (B) Co-transfection of TauEx9-11N279K with TauPTM9 resulted in the appearance of E10- products. Co-transfection with TauPTM6 had no effect on E10 inclusion. (D) The TauEx9-11Delta280K minigene produces both E10+ and E10- RNA, with a slight excess of E10- RNA. Co-transfection with TauPTM6 or TauPTM9 increased or reduced E10 inclusion, respectively.
###end p 22
###begin p 23
###xml 112 114 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C16">16</xref>
###xml 155 156 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 233 242 225 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
###xml 249 250 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
###xml 283 289 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 315 324 303 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
###xml 455 456 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F6">6</xref>
###xml 533 538 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 585 588 569 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
The ESE strengthened by the N279 mutation is weakened by the Delta280K deletion, causing reduced E10 inclusion (16). In transfected cells, an excess of E10- RNA is produced from a minigene containing the Delta280K mutation, TauEx9-11Delta280K (Fig. 3B). RT-PCR analysis demonstrated trans-splicing between TauEx9-11Delta280K transcripts and either TauPTM6 or Tau PTM9 and a resulting increase or decrease in the level of E10 inclusion, respectively (Fig. 6C, D). Taken together, these results show that E10 usage can be modulated by trans-splicing independently of the strength of the cis-regulatory elements in the targets.
###end p 23
###begin title 24
DISCUSSION
###end title 24
###begin p 25
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C13">13</xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 495 498 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 685 690 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 735 738 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
In this study, we have demonstrated that aberrant tau E10 splicing resulting from FTDP-17 mutations can be partially corrected by trans-splicing. We showed previously that cis-splicing exclusion of E10 could be by-passed by trans-splicing and that E10- to E10+ tau RNA conversion could be achieved from wild-type tau sequences (13). The demonstration that E10 inclusion can be reduced as well as increased by trans-splicing shows that trans-splicing can occur irrespective of the outcome of the cis-splicing event determined by the combination of splicing factors recruited by an individual pre-mRNA. Importantly, correction of aberrant splicing caused by FTDP-17 mutations shows that trans-splicing can be achieved in the presence of cis-splicing elements of altered strength.
###end p 25
###begin p 26
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C14">14</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C15">15</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C20">20</xref>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C4">4</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C9">9</xref>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 706 712 706 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Most intronic FTDP-17 mutations are clustered at the exon 10-intron 10 junction. This region is predicted to form a stem-loop structure regulating E10 splicing by protecting the 5' splice site. FTDP-17 mutations +3 to +16, as well as the exonic S305N mutation, destabilize the stem loop making the 5' splice site of intron 10 constitutively available, hence promoting E10 inclusion (14,15,20). E10 retention results in a 1.5- to 6-fold increase in the E10+/E10- ratio (4,9). Trans-splicing was achieved using a target carrying the very potent DDPAC +14 mutation and produced mature RNA lacking E10 demonstrating that the constitutive availability of the 5' splice site of intron 10 does not interfere with trans-splicing.
###end p 26
###begin p 27
###xml 313 315 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C16">16</xref>
###xml 316 318 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C17">17</xref>
###xml 319 321 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C21">21</xref>
###xml 365 369 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 497 499 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C22">22</xref>
###xml 500 502 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C23">23</xref>
###xml 505 510 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 773 778 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 898 904 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 1027 1033 1010 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
The N279K mutation, within E10, strengthens an ESE and facilitates the use of the 3' splice site of intron 9. The affinity of the splicing factors, Tra2beta and SF2/ASF, for the ESE is enhanced by the N279K mutation and, conversely, Tra2beta and SF2/ASF affinity for the ESE is reduced by the Delta280K deletion (16,17,21). The Delta280K mutation is the only known MAPT mutation that reduces E10 inclusion and is associated with lesions containing exclusively, or, at least predominantly, 3R tau (22,23). Trans-splicing obtained with the N279K mutation and subsequent production of RNA lacking E10 shows that enhanced availability of the 3' splice site of intron 9 in the target does not interfere with the use of the 3' splice site from the PTM, which is required for the trans-splicing reaction. Therefore abnormal binding of Tra2beta and/or SF2/ASF to the ESE within the target does not inhibit trans-splicing modulation of E10 usage in either direction. However, its efficiency might be influenced by the interplay between trans-acting factors recruited on the target and on the PTM.
###end p 27
###begin p 28
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C24">24</xref>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 374 375 374 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C25">25</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C26">26</xref>
The possibility of correcting E10 inclusion is relevant not only for FTDP-17 but also for sporadic tauopathies. A single molecule analysis of tau isoforms in Alzheimer's disease brain revealed an increase to 1.3 in the E10+/E10- ratio (24). In addition, the H1 haplotype of the MAPT gene, which is associated with an increased risk of Alzheimer's disease, expresses more E10+ tau mRNA than the H2 haplotype (25,26).
###end p 28
###begin p 29
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C27">27</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C28">28</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C29">29</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C30">30</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C33">33</xref>
###xml 475 477 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C34">34</xref>
###xml 587 589 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C35">35</xref>
###xml 634 636 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C36">36</xref>
###xml 664 666 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C37">37</xref>
###xml 667 669 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C38">38</xref>
###xml 695 697 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C39">39</xref>
###xml 850 852 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C40">40</xref>
###xml 853 855 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C41">41</xref>
###xml 895 901 889 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 1069 1071 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C36">36</xref>
###xml 1072 1074 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C38">38</xref>
###xml 1075 1077 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C42">42</xref>
###xml 1078 1080 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C44">44</xref>
###xml 1304 1310 1298 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans-</italic>
###xml 1500 1502 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C45">45</xref>
###xml 1438 1446 <span type="species:ncbi:9606">patients</span>
Several chemical inhibitors of E10 inclusion have been identified through high throughput screening and could provide drug leads (27,28). However, RNA-based therapies are gaining increasing popularity due to their specificity and versatility (29). Among those, SMaRT has proved to be a very powerful method to correct loss-of-function mutations at the RNA level (30-33). Recent applications have included correction of beta-globin in sickle-cell anemia and beta-thalassemia (34), plectin (PLEC1) in blistering skin disease epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) (35), severe combined immune deficiency (SCID) (36), spinal muscular atrophy (37,38) and myotonic dystrophy (39). Gene therapy for brain diseases is still at an early stage, but several classes of viral vectors have been developed for the transduction of neurons (40,41). Furthermore, long-term expression of trans-splicing molecules obtained using viral vectors or transposon systems has been shown to result in recovery of functional defects compatible with a therapeutic benefit (36,38,42-44). The level of tau E10 splicing correction necessary for a detectable phenotypic effect is not known, neither is the precise consequence of tau isoform imbalance on microtubule properties and functions or on neurotoxicity. Trans-splicing reduction of E10 inclusion on endogenous tau could be optimized in induced pluripotent stem cells derived from FTDP-17 patients, when available, after differentiation into neurons (45).
###end p 29
###begin p 30
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C46">46</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C49">49</xref>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
An increasing number of neurological and other disorders are being associated with aberrant alternative splicing (46-49) and SMaRT would be an approach to be developed to correct aberrant splicing caused by pathogenic mutations in cis-acting splicing elements.
###end p 30
###begin title 31
MATERIALS AND METHODS
###end title 31
###begin title 32
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Pre-trans-splicing molecules
###end title 32
###begin p 33
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C13">13</xref>
The pre-trans-splicing molecule, TauPTM6, in the mammalian expression vector, pcDNA3.1, has been described previously (13). TauPTM6 is designed to include E10 in tau RNA; its coding sequence consists of tau exons 10-13, followed by a FLAG epitope sequence (5'-GACTACAAGGACGACGATGACAAG-3'). TauPTM9, designed to exclude E10 from tau RNA, was generated by deleting E10 from TauPTM6, using restriction digestions and ligation of synthetic oligonucleotides.
###end p 33
###begin title 34
Tau minigene targets
###end title 34
###begin p 35
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C18">18</xref>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</sup>
###xml 239 244 239 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP264C19">19</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP264F3">3</xref>
###xml 461 466 461 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDPAC</sup>
###xml 560 565 560 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N279K</sup>
###xml 579 588 579 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;280K</sup>
The LI9/LI10 minigene in the pCIneo vector comprises tau exons 9-10-11 and full-length introns 9 and 10 (18) and was obtained from Dr Jianhua Zhou (University of Massachusetts Medical School, Worcester). Minigenes TauEx9-11WT and TauEx9-11DDPAC comprising tau exons 9-10-11 and 498 bp of 5' and 264 bp 3' of intronic sequences flanking E10 (19) (Fig. 3) were obtained from Dr Jane Wu (Northwestern University Feinberg School of Medicine, Chicago). The TauEx9-11DDPAC minigene carries the intronic +14 DDPAC FTDP-17 mutation. Two additional minigenes, TauEx9-11N279K and TauEx9-11Delta280K were constructed by introducing the exonic N279K and Delta280K mutations into TauEx9-11 using the Quick-Change site-directed mutagenesis kit (Stratagene). Wild-type and mutant minigenes based on TauEx9-11 were subcloned into pCIneo. All constructs were verified by sequencing.
###end p 35
###begin title 36
Cell culture and transfection
###end title 36
###begin p 37
###xml 153 154 149 150 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 154 155 150 151 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 210 211 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
COS-7 cells were maintained in DMEM supplemented with 10% (v/v) heat inactivated FBS (Invitrogen), 100 U/ml penicillin/100 microg/ml streptomycin and 2 mml-glutamine, in a humidified atmosphere of 95% air/5% CO2 at 37degreesC. Cells were transfected with Lipofectamine 2000 reagent (Invitrogen). Briefly, cells plated on 35 mm dishes were grown to 60-70% confluency and exposed to the DNA/liposome complex for 5 h in Optimem (Invitrogen) before being returned to normal culture medium. Cells were routinely analyzed 24 h after transfection. Cells were transfected with either tau minigene plus empty vector or PTM plus empty vector, or co-transfected with minigene and PTM. Typically, 2 microg minigene and 2 microg PTM were used in each transfection.
###end p 37
###begin title 38
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
RT-PCR analysis of cis- and trans-splicing
###end title 38
###begin p 39
###xml 190 192 181 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 398 401 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 728 732 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 737 743 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 781 782 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP264TB1">1</xref>
###xml 1107 1108 1050 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1115 1116 1058 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1221 1222 1164 1165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1267 1268 1210 1211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1281 1282 1224 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1284 1285 1227 1228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1288 1289 1231 1232 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Total RNA was isolated from transfected cells using Trizol reagent (Invitrogen). Reverse transcription was performed using the Multiscribetrade mark RT kit (Applied Biosystem) and oligo-(dT)16. Reverse transcription was carried out under the following conditions: 10 min at 25degreesC, 30 min at 48degreesC and a final step of 5 min at 95degreesC. Reverse transcribed RNA was amplified by using Go Taq polymerase (Promega) under the following conditions: 94degreesC for 5 min, 30 cycles of 1 min at 94degreesC, 1 min at 58degreesC, 1 min at 72degreesC and a final step of 10 min at 72degreesC. An extension time of 3 min was used in reactions designed to visualize DNA. The sequence of the primers used for PCR and the sizes of cis- and trans-splicing products are listed in Table 1. PCR products were separated by electrophoresis in 2% (w/v) agarose gels and stained with ethidium bromide. Densitometric analysis of triplicate experiments was performed using the Innotech software (Alpha Innotech, San Leandro, CA, USA). Splicing activity was expressed as percentage of E10 inclusion. The efficiency of E10+ to E10- conversion was estimated from the percentage of E10 inclusion in cells transfected with minigene only (p1) and co-transfected with minigene and PTM (p2) as 100 x (p1-p2)/p1. For sequencing, PCR products were excised from agarose gels and cloned into the pCR2.1 vector using the TA cloning system (Invitrogen). Sequencing of both strands was performed using T3 and T7 primers.
###end p 39
###begin p 40
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
Sequence of the PCR primers used to detect cis- and trans-splicing products and sizes of the corresponding products
###end p 40
###begin p 41
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
###xml 328 332 328 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis-</italic>
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans-</italic>
The forward primer, VctF, corresponds to a sequence in the pCIneo vector and is specific for the target minigenes. The FLAGR reverse primer, complementary to a FLAG epitope sequence, is specific for PTMs and was used to demonstrate trans-splicing. The reverse primer 11R is complementary to an exon 11 sequence and detects both cis- and trans-spliced products.
###end p 41
###begin title 42
FUNDING
###end title 42
###begin p 43
###xml 31 45 31 45 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wellcome Trust</funding-source>
###xml 51 105 51 105 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Biotechnology and Biological Sciences Research Council</funding-source>
###xml 107 135 107 135 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the Medical Research Council</funding-source>
###xml 137 178 137 178 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ataxia UK, the Alzheimer's Research Trust</funding-source>
###xml 183 212 183 212 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the Psychiatry Research Trust</funding-source>
This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the Medical Research Council, Ataxia UK, the Alzheimer's Research Trust and the Psychiatry Research Trust. Funding to pay the Open Access publication charges for this article was provided by the Wellcome Trust.
###end p 43
###begin title 44
ACKNOWLEDGEMENTS
###end title 44
###begin p 45
We thank Drs Jianhua Zhou and Jane Wu for tau minigenes.
###end p 45
###begin p 46
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. M.A.G.-B. is a founder of Intronn, a company that was set up for the development and commercialization of the SMaRT technology. Intronn has been bought by VIRxSYS and M.G.-B. is a consultant for VIRxSYS. S.G.M. is an employee of VIRxSYS.
###end p 46
###begin title 47
REFERENCES
###end title 47
###begin article-title 48
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
###end article-title 48
###begin article-title 49
RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies
###end article-title 49
###begin article-title 50
Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau
###end article-title 50
###begin article-title 51
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17
###end article-title 51
###begin article-title 52
Tau is a candidate gene for chromosome 17 frontotemporal dementia
###end article-title 52
###begin article-title 53
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
###end article-title 53
###begin article-title 54
Tau alteration and neuronal degeneration in tauopathies: mechanisms and models
###end article-title 54
###begin article-title 55
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
###end article-title 55
###begin article-title 56
Quantitative analysis of tau isoform transcripts in sporadic tauopathies
###end article-title 56
###begin article-title 57
Differential regulation of dynein and kinesin motor proteins by tau
###end article-title 57
###begin article-title 58
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Spliceosome-mediated RNA trans-splicing as a tool for gene therapy
###end article-title 58
###begin article-title 59
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
5' exon replacement and repair by spliceosome-mediated RNA trans-splicing
###end article-title 59
###begin article-title 60
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies
###end article-title 60
###begin article-title 61
5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
###end article-title 61
###begin article-title 62
Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing
###end article-title 62
###begin article-title 63
Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
###end article-title 63
###begin article-title 64
Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2beta
###end article-title 64
###begin article-title 65
A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10
###end article-title 65
###begin article-title 66
Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17
###end article-title 66
###begin article-title 67
FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10
###end article-title 67
###begin article-title 68
Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K and N279K
###end article-title 68
###begin article-title 69
###xml 58 65 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo
###end article-title 69
###begin article-title 70
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 61 68 <span type="species:ncbi:9606">patient</span>
Clinical and pathological features of an Alzheimer's disease patient with the MAPT DeltaK280 mutation
###end article-title 70
###begin article-title 71
Single molecule profiling of tau gene expression in Alzheimer's disease
###end article-title 71
###begin article-title 72
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Haplotype-specific expression of exon 10 at the human MAPT locus
###end article-title 72
###begin article-title 73
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPT</italic>
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts
###end article-title 73
###begin article-title 74
Identification of tau stem loop RNA stabilizers
###end article-title 74
###begin article-title 75
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators
###end article-title 75
###begin article-title 76
Modulating the expression of disease genes with RNA-based therapy
###end article-title 76
###begin article-title 77
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing
###end article-title 77
###begin article-title 78
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
RNA repair using spliceosome-mediated RNA trans-splicing
###end article-title 78
###begin article-title 79
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Spliceosome-mediated RNA trans-splicing
###end article-title 79
###begin article-title 80
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Gene therapy progress and prospects: reprograming gene expression by trans-splicing
###end article-title 80
###begin article-title 81
Using 5'-PTMs to repair mutant beta-globin transcripts
###end article-title 81
###begin article-title 82
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
5' trans-splicing repair of the PLEC1 gene
###end article-title 82
###begin article-title 83
Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and Sleeping Beauty transposon delivery
###end article-title 83
###begin article-title 84
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Restoration of SMN function: Delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing
###end article-title 84
###begin article-title 85
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMN2</italic>
Development of a single vector system that enhances trans-splicing of SMN2 transcripts
###end article-title 85
###begin article-title 86
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing
###end article-title 86
###begin article-title 87
###xml 45 50 <span type="species:ncbi:9606">human</span>
Lentiviral vectors for treating and modeling human CNS disorders
###end article-title 87
###begin article-title 88
Transduction patterns of pseudotyped lentiviral vectors in the nervous system
###end article-title 88
###begin article-title 89
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing
###end article-title 89
###begin article-title 90
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency
###end article-title 90
###begin article-title 91
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 57 79 <span type="species:ncbi:272636">adeno-associated virus</span>
###xml 173 178 <span type="species:ncbi:9606">human</span>
Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells
###end article-title 91
###begin article-title 92
Disease-specific induced pluripotent stem cells
###end article-title 92
###begin article-title 93
###xml 22 27 <span type="species:ncbi:9606">human</span>
Pre-mRNA splicing and human disease
###end article-title 93
###begin article-title 94
Alternative splicing in disease and therapy
###end article-title 94
###begin article-title 95
The role of RNA and RNA processing in neurodegeneration
###end article-title 95
###begin article-title 96
Splicing regulation in neurologic disease
###end article-title 96

